Article Details
Retrieved on: 2021-04-22 11:17:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Developed by SAB Biotherapeutics, SAB-185 has shown to neutralise live SARS-CoV-2 at titers higher than convalescent plasma in pre-clinical ...
Article found on: www.clinicaltrialsarena.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here